Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Ketamine 50 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient, offering sustained therapeutic effects. These capsules are used to treat conditions such as depression, anxiety, chronic pain, PTSD, and fibromyalgia. The slow release mechanism reduces dosing frequency and improves patient compliance, providing prolonged relief.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to introduce our new slow release formulation of Ketamine 50 mg capsules. This innovative formulation utilizes Methocel E4M, a controlled-release polymer, to gradually release the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The sustained release of ketamine provides a consistent therapeutic effect, reducing symptoms of depression such as feelings of sadness, hopelessness, and fatigue. It also helps alleviate anxiety by reducing feelings of fear and worry.
Furthermore, this formulation has shown efficacy in treating chronic pain, helping to reduce pain intensity and improve the quality of life for patients.
While the slow release Ketamine 50 mg capsule formulation is a appropriate treatment option for a variety of conditions, it is important to note that ketamine should be used with caution in patients with a history of substance abuse or mental health issues. Additionally, ketamine should not be used in combination with other medications, as this could lead to serious side effects.
If you have any questions about the slow release Ketamine 50 mg capsule formulation or how it can be used to treat various disease states, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the best treatment option tailored to your individual needs.
Ketamine 50 mg Slow Release Capsules are a compounded formulation designed to provide a controlled and prolonged release of the active ingredient, Ketamine. This is achieved through the use of Methocel E4M, a type of controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled release profile.
It's important to note that Ketamine 50 mg Slow Release Capsules may interact with other medications. This includes medications used to treat depression, anxiety, chronic pain, and post-traumatic stress disorder (PTSD). Therefore, patients are advised to inform their healthcare provider of all medications they are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements.
Patients should also disclose any other medical conditions they may have, as well as any allergies to medications. It's crucial to avoid taking Ketamine 50 mg Slow Release Capsules if you are currently on monoamine oxidase inhibitors (MAOIs) or have a history of seizures. Additionally, alcohol should be avoided while taking this medication.
Patients should not discontinue the use of Ketamine 50 mg Slow Release Capsules without first consulting their healthcare provider. If any side effects occur, it's important to contact your healthcare provider immediately. If you have any questions or concerns about the use of Ketamine 50 mg Slow Release Capsules, please consult with your healthcare provider for further guidance.
Ketamine 50 mg Slow Release Capsules are a specialized medication designed to treat a range of conditions including depression, anxiety, chronic pain, and post-traumatic stress disorder (PTSD). The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, ketamine, over an extended period. This slow release mechanism provides a consistent therapeutic effect, reducing the need for frequent dosing and enhancing patient compliance.
The capsules are administered orally, typically once a day, and should be consumed with food. It is crucial to adhere to the dosage prescribed by your healthcare provider, avoiding any deviation from the recommended amount. Ketamine functions by inhibiting certain receptors in the brain, thereby alleviating symptoms associated with depression, anxiety, and chronic pain. It also mitigates the severity of PTSD symptoms such as flashbacks and nightmares. The slow release formulation ensures a steady concentration of the medication in the body, minimizing the likelihood of side effects.
Common side effects associated with ketamine include dizziness, nausea, headache, and confusion. If you experience any of these symptoms, it is important to consult your doctor as they may need to adjust your dosage or consider an alternative medication. It is also crucial to be cognizant of the potential for abuse and addiction associated with ketamine, and to strictly adhere to the prescribed dosage.
If you have any queries or concerns regarding Ketamine 50 mg Slow Release Capsules, please do not hesitate to contact us. We are committed to helping you understand the workings of this medication and how it can assist in managing your symptoms.
Ketamine 50 mg Slow Release Capsules, formulated with Methocel E4M, a controlled-release polymer, are designed to gradually release the encapsulated medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules have been used to treat a wide range of conditions. They have shown efficacy in the treatment of bipolar disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. They have also been used to manage chronic pain conditions, including neuropathic pain and fibromyalgia. Furthermore, they have been used in the treatment of refractory depression and anxiety.
Off-label uses of Ketamine 50 mg Slow Release Capsules include the treatment of chronic fatigue syndrome, irritable bowel syndrome, and other chronic pain conditions. They can be used as an adjunct to other medications or as a stand-alone treatment.
It is crucial to note that ketamine should be used with caution in patients with a history of substance abuse, as it has the potential to be habit-forming. If you have any questions about the use of Ketamine 50 mg Slow Release Capsules for any of these conditions, please consult with a healthcare professional.
The main ingredient in these capsules is Ketamine 50 mg.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to release the encapsulated medication gradually over an extended period of time.
The use of Methocel E4M in the formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
The slow release mechanism works by gradually releasing the encapsulated medication over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer.
'Sustained therapeutic effects' means that the medication continues to have its intended therapeutic effect over a longer period of time, due to the slow release of the active ingredient.
Reduced dosing frequency means that the patient needs to take the medication less often. This can improve patient compliance, as it is easier to remember to take the medication and it can also reduce the risk of side effects associated with frequent dosing.
'Improved patient compliance' means that patients are more likely to take the medication as prescribed.
A 'controlled and prolonged release profile' refers to the way in which the medication is released into the body. In this case, the medication is released gradually over an extended period of time, providing a steady and prolonged therapeutic effect.
As with any medication, there may be side effects associated with this formulation. However, the use of a controlled-release polymer like Methocel E4M can help to reduce the risk of side effects associated with frequent dosing.
These capsules should be used by patients who have been prescribed Ketamine 50 mg by their healthcare provider. The slow release formulation is particularly beneficial for patients who require a controlled and prolonged release profile for their medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
